These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22551310)

  • 1. Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease.
    El-Hodhod MA; Hamdy AM; Abbas AA; Moftah SG; Ramadan AA
    BMC Gastroenterol; 2012 May; 12():44. PubMed ID: 22551310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease.
    Silvennoinen J
    J Intern Med; 1996 Feb; 239(2):131-7. PubMed ID: 8568480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Scand J Gastroenterol; 2002 Feb; 37(2):192-9. PubMed ID: 11843057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Status and Bone Mineral Density in Children with Inflammatory Bowel Disease Compared to Those with Functional Abdominal Pain.
    Sohn J; Chang EJ; Yang HR
    J Korean Med Sci; 2017 Jun; 32(6):961-967. PubMed ID: 28480654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease.
    Sylvester FA; Wyzga N; Hyams JS; Davis PM; Lerer T; Vance K; Hawker G; Griffiths AM
    Inflamm Bowel Dis; 2007 Jan; 13(1):42-50. PubMed ID: 17206638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
    Scharla SH; Minne HW; Lempert UG; Leidig G; Hauber M; Raedsch R; Ziegler R
    Exp Clin Endocrinol; 1994; 102(1):44-9. PubMed ID: 8005208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density improves with disease remission in patients with inflammatory bowel disease.
    Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density assessment in children with inflammatory bowel disease.
    Gokhale R; Favus MJ; Karrison T; Sutton MM; Rich B; Kirschner BS
    Gastroenterology; 1998 May; 114(5):902-11. PubMed ID: 9558278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone density and bone metabolism in patients with inflammatory bowel disease.
    Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
    Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.
    Abreu MT; Kantorovich V; Vasiliauskas EA; Gruntmanis U; Matuk R; Daigle K; Chen S; Zehnder D; Lin YC; Yang H; Hewison M; Adams JS
    Gut; 2004 Aug; 53(8):1129-36. PubMed ID: 15247180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
    Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
    Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
    Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
    Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Casals-Seoane F; Chaparro M; Maté J; Gisbert JP
    Inflamm Bowel Dis; 2016 Aug; 22(8):1929-36. PubMed ID: 27135482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower fibroblast growth factor 23 levels in young adults with Crohn disease as a possible secondary compensatory effect on the disturbance of bone and mineral metabolism.
    Oikonomou KA; Orfanidou TI; Vlychou MK; Kapsoritakis AN; Tsezou A; Malizos KN; Potamianos SP
    J Clin Densitom; 2014; 17(1):177-84. PubMed ID: 23623649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.
    Pappa HM; Saslowsky TM; Filip-Dhima R; DiFabio D; Hassani Lahsinoui H; Akkad A; Grand RJ; Gordon CM
    Am J Gastroenterol; 2011 Aug; 106(8):1527-43. PubMed ID: 21519359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.
    Kuwabara A; Tanaka K; Tsugawa N; Nakase H; Tsuji H; Shide K; Kamao M; Chiba T; Inagaki N; Okano T; Kido S
    Osteoporos Int; 2009 Jun; 20(6):935-42. PubMed ID: 18825300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.
    Abraham BP; Prasad P; Malaty HM
    Dig Dis Sci; 2014 Aug; 59(8):1878-84. PubMed ID: 24619280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.